| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 672215 | Null | 0.045446901295916 | 0.50429479 |
| NSC 676914 | 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid | 0.045446901295916 | 0.48186736 |
| NSC 678925 | 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride | 0.045446901295916 | 0.41399755 |
| NSC 681239 | Bortezomib | 0.045446901295916 | -0.06121636 |
| NSC 681636 | Camptothecin Derivative | 0.045446901295916 | 0.39756691 |
| NSC 682764 | Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- | 0.045446901295916 | -0.14965028 |
| NSC 683558 | Camptothecin Derivative | 0.045446901295916 | 0.42187085 |
| NSC 684440 | Null | 0.045446901295916 | 0.32453653 |
| NSC 687305 | 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone | 0.045446901295916 | 0.48303745 |
| NSC 715572 | Null | 0.0454469012959163 | 0.080162055 |